Polyps Companies

Exact Sciences and Invitae partner to offer combined Cologuard and genetic testing for colorectal cancer screening. This collaboration aims to provide a more comprehensive approach to early detection. (Oct 5, 2023)

Boston Scientific receives FDA approval for its ExacTech EchoPulse System, an advanced needle guidance technology for colorectal biopsies. This system aims to improve accuracy and minimize complications associated with traditional biopsies. (Sep 20, 2023)

Growing research on the potential of artificial intelligence (AI) in polyp detection and analysis. Studies show AI algorithms can accurately identify polyps in colonoscopies, potentially improving diagnosis and reducing miss rates. (Jan 17, 2024)

Dupixent (dupilumab) approved for chronic rhinosinusitis with nasal polyps. This injectable medication offers a new treatment option for patients with severe nasal polyps. (Jan 6, 2024)

SonoClear Technologies receives FDA clearance for its Rhinostat device, a minimally invasive treatment for nasal polyps. This device uses radiofrequency energy to shrink polyps without surgery. (Nov 17, 2023) Focus on developing new technologies for non-invasive and more comfortable nasal polyp removal procedures. These include advancements in balloon sinuplasty and endoscopic techniques. (Dec 22, 2023)

• Millennium Surgical Corp.


• Black Smith Surgical


• B. Braun Melsungen AG


• Medtronic


• Cook Medical


• Endo Pharmaceuticals Inc.


• Pfizer Inc.


• Teva Pharmaceutical Industries Ltd.


• Novartis AG


• Mylan Inc.


• Sun Pharmaceuticals